Your browser is no longer supported. Please, upgrade your browser.
ISR Isoray, Inc. monthly Stock Chart
ISR [AMEX]
Isoray, Inc.
Index- P/E- EPS (ttm)-0.05 Insider Own0.85% Shs Outstand68.07M Perf Week8.39%
Market Cap37.97M Forward P/E- EPS next Y-0.02 Insider Trans41.89% Shs Float68.01M Perf Month-28.63%
Income-3.50M PEG- EPS next Q-0.01 Inst Own10.40% Short Float1.93% Perf Quarter-34.61%
Sales9.70M P/S3.91 EPS this Y33.50% Inst Trans0.53% Short Ratio2.45 Perf Half Y-34.93%
Book/sh0.08 P/B5.20 EPS next Y40.00% ROA-37.70% Target Price- Perf Year34.19%
Cash/sh- P/C- EPS next 5Y- ROE-56.10% 52W Range0.30 - 1.06 Perf YTD-33.38%
Dividend- P/FCF- EPS past 5Y5.30% ROI-61.00% 52W High-60.75% Beta1.96
Dividend %- Quick Ratio3.10 Sales past 5Y16.00% Gross Margin52.90% 52W Low38.57% ATR0.04
Employees53 Current Ratio3.50 Sales Q/Q21.10% Oper. Margin-35.70% RSI (14)32.77 Volatility9.65% 5.95%
OptionableNo Debt/Eq0.00 EPS Q/Q-7.40% Profit Margin-35.70% Rel Volume1.49 Prev Close0.42
ShortableYes LT Debt/Eq0.00 EarningsSep 17 AMC Payout- Avg Volume536.32K Price0.42
Recom2.00 SMA20-16.18% SMA50-28.15% SMA200-37.26% Volume0 Change0.00%
Nov-09-18Downgrade Maxim Group Buy → Hold
Feb-14-18Reiterated Maxim Group Buy $3 → $2
Nov-10-15Reiterated Maxim Group Buy $5 → $3
Jul-16-14Resumed Maxim Group Buy $3.50 → $5
Apr-02-14Reiterated Maxim Group Buy $1.50 → $3.50
Nov-01-13Initiated Maxim Group Buy $1.50
Mar-17-10Initiated C.K. Cooper Buy $1.70
Aug-21-08Downgrade Ladenburg Thalmann Buy → Neutral
May-14-08Reiterated Ladenburg Thalmann Buy $2 → $1.50
Feb-13-08Reiterated Punk, Ziegel & Co Buy $6.25 → $2
Sep-24-07Initiated Punk, Ziegel & Co Buy $6.25
Oct-20-20 09:00AM  
Oct-19-20 04:56PM  
Sep-19-20 09:49AM  
Sep-17-20 05:15PM  
04:05PM  
Sep-16-20 08:13AM  
Sep-10-20 08:13AM  
Jul-28-20 10:14AM  
Jun-19-20 07:06PM  
Jun-17-20 08:13AM  
Jun-04-20 12:00PM  
Jun-02-20 08:13AM  
May-14-20 09:50AM  
May-12-20 05:55PM  
04:17PM  
04:08PM  
May-05-20 12:30PM  
May-04-20 08:13AM  
Apr-27-20 09:04AM  
Apr-09-20 12:00PM  
Mar-22-20 09:01AM  
Feb-17-20 06:31PM  
Feb-14-20 12:00PM  
Feb-11-20 05:45PM  
04:05PM  
Feb-05-20 08:13AM  
Feb-04-20 12:30PM  
Jan-31-20 08:13AM  
Jan-14-20 09:11AM  
Dec-09-19 12:06PM  
Dec-04-19 01:23PM  
Nov-13-19 09:00AM  
Nov-12-19 06:26PM  
04:05PM  
Nov-05-19 10:32AM  
Nov-01-19 01:15PM  
Oct-31-19 08:13AM  
Oct-29-19 08:13AM  
Sep-30-19 11:06AM  
Sep-27-19 09:00AM  
Sep-26-19 12:51PM  
Sep-24-19 05:25PM  
04:05PM  
02:30PM  
Sep-18-19 08:13AM  
Sep-12-19 08:13AM  
Sep-10-19 08:13AM  
Aug-21-19 02:14PM  
Aug-13-19 08:05AM  
Jun-21-19 11:03AM  
Jun-12-19 08:13AM  
May-23-19 10:04AM  
May-09-19 07:45PM  
06:39PM  
04:05PM  
May-01-19 08:13AM  
Apr-25-19 10:34AM  
Apr-16-19 08:11AM  
Feb-12-19 06:20PM  
05:19PM  
04:05PM  
02:30PM  
Feb-05-19 10:30AM  
Jan-30-19 08:13AM  
Jan-29-19 08:13AM  
Dec-17-18 08:13AM  
Dec-03-18 08:13AM  
Nov-26-18 08:40AM  
Nov-08-18 07:05PM  
06:03PM  
04:05PM  
Oct-24-18 08:13AM  
Sep-25-18 04:21PM  
04:05PM  
07:21AM  
Sep-10-18 08:15AM  
Sep-07-18 08:11AM  
Jul-23-18 07:00AM  
Jul-12-18 08:30AM  
Jul-10-18 09:21AM  
08:10AM  
Jul-09-18 07:58PM  
01:52PM  
Jun-19-18 08:00AM  
Jun-05-18 08:00AM  
May-31-18 08:30AM  
May-30-18 08:00AM  
May-25-18 08:17PM  
May-17-18 08:30AM  
May-16-18 07:55PM  
08:30AM  
May-11-18 08:30AM  
May-03-18 06:33PM  
04:05PM  
May-02-18 08:30AM  
Apr-26-18 08:00AM  
Apr-24-18 09:05AM  
Apr-19-18 09:00AM  
Apr-18-18 08:30AM  
Feb-09-18 05:01AM  
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company produces CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and neck, gynecological, pelvic/abdominal, and colorectal cancers, as well as ocular melanoma. It sells its products to facilities or physician practices that utilize multiple surgical facilities at which primarily prostate brachytherapy procedures are performed. Isoray, Inc. was founded in 1998 and is headquartered in Richland, Washington.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Austin Mark JohnController/Prin Fin&Acct OfficOct 22Buy0.5219,23010,00035,230Oct 28 04:46 PM
Krachon MichaelEVP of Sales & MarketingOct 22Buy0.5228,84414,99983,844Oct 28 04:45 PM
Hunt Jonathan RobertChief Financial OfficerOct 22Buy0.5267,30634,99967,306Oct 28 04:43 PM
Cavanagh WilliamChief R&D OfficerOct 22Buy0.527,6924,00027,692Oct 28 04:41 PM
McCormick Michael WDirectorOct 22Buy0.5219,23010,00041,230Oct 28 04:40 PM
Hoffmann AlanDirectorOct 22Buy0.5219,23010,00019,230Oct 28 04:38 PM
Vitale Philip JDirectorOct 22Buy0.5220,00010,400130,000Oct 28 04:37 PM
Woods Lori ACEOOct 22Buy0.5248,07625,00048,076Oct 28 04:35 PM
Woods Lori ACEOFeb 03Option Exercise0.49262,500129,750542,500Feb 05 04:47 PM
Krachon MichaelVP of Sales & MarketingNov 20Buy0.3950,00019,49550,000Nov 21 04:30 PM
Cavanagh WilliamChief R&D OfficerNov 15Buy0.3910,0003,90020,000Nov 19 05:01 PM
Woods Lori ACEONov 15Buy0.3925,0009,745280,000Nov 19 05:04 PM
Woods Lori ACEONov 14Buy0.40125,00049,550255,000Nov 19 05:04 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.